Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

August 1, 2025

Conditions

Mood Disturbance

Interventions

DIETARY_SUPPLEMENT

Curcumin

1,330 mg curcumin

DIETARY_SUPPLEMENT

Epigallocatechin Gallate

350 mg Epigallocatechin gallate (EGCG)

OTHER

Placebo

Placebo to be consumed after randomization.

Trial Locations (1)

RECRUITING

Auburn University School of Kinesiology, Auburn

All Listed Sponsors

lead

Auburn University

OTHER